Publication Venue For
AKI!Now Initiative: Recommendations for Awareness, Recognition, and Management of AKI.
Fibroblast Growth Factor 23 and the Last Mile.
Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD.
Endpoints for Clinical Trials in Primary Hyperoxaluria.
Pregnancy in a kidney transplant patient.
Prevention of bloodstream infections in patients undergoing hemodialysis.
Apol1 nephropathy risk alleles and risk of sepsis in blacks.
Self-reported incident hypertension and long-term kidney function in living kidney donors compared with healthy nondonors.
Early glomerular hyperfiltration and long-term kidney outcomes in type 1 diabetes: The DCCT/EDIC experience.
Growth pattern of kidney cyst number and volume in autosomal dominant polycystic kidney disease.
Quality improvement goals for acute kidney injury.
Vascular access for hemodialysis patients: New data should guide decision making.
Post-transplant lymphoproliferative disorder in a kidney transplant recipient.
Kidney transplantation in a HIV-positive recipient.
Management of the hemodialysis patient with catheter-related bloodstream infection.
Incidence and risk factors of early onset neonatal AKI.
PTH, FGF23, and intensive blood pressure lowering in chronic kidney disease participants in SPRINT.
Association of preexisting arterial intimal hyperplasia with arteriovenous fistula outcomes.
Postoperative ultrasound, unassisted maturation, and subsequent primary patency of arteriovenous fistulas.
Expand the pool of living donors for kidney transplantation.
Overcoming translational barriers in acute kidney injury: A report from an NIDDK workshop.
Clinical trial end points for hemodialysis vascular access: Background, rationale, and definitions.
Definitions and end points for interventional studies for arteriovenous dialysis access.
Recommended clinical trial end points for dialysis catheters.
Challenges in developing new therapies for vascular access dysfunction.
Perspectives from the kidney health initiative on advancing technologies to facilitate remote monitoring of patient self-care in RRT.
Vascular access type and clinical outcomes among elderly patients on hemodialysis.
Managing issues in dialysis for the patient with AKI.
Access to kidney transplantation among HIV-infected waitlist candidates.
Diagnosis, treatment, and prevention of hemodialysis emergencies.
Reassessing recommendations for choice of vascular access.
Survival benefit of transplantation with a deceased diabetic donor kidney compared with remaining on the waitlist.
The use of a multidimensional measure of dialysis adequacy—moving beyond small solute kinetics.
Predictors of initiation for predialysis arteriovenous fistula.
Automated segmentation of kidneys from mr images in patients with autosomal dominant polycystic kidney disease.
Genetic african ancestry and markers of mineral metabolism in CKD.
Association of dialysis duration with outcomes after transplantation in a Japanese cohort.
Visit-to-visit variability of BP and CKD outcomes: Results from the ALLHAT.
Acute kidney injury urine biomarkers in very low-birth-weight infants.
Albuminuria changes and cardiovascular and renal outcomes in type 1 diabetes: The DCCT/EDIC study.
Association of peritonitis with hemodialysis catheter dependence after modality switch.
Association of reduced eGFR and albuminuria with serious fall injuries among older adults.
New insights into dialysis vascular access: Impact of preexisting arterial and venous pathology on AVF and AVG outcomes.
New insights into dialysis vascular access: Introduction.
New insights into dialysis vascular access: Molecular targets in arteriovenous fistula and arteriovenous graft failure and their potential to improve vascular access outcomes.
Paraprotein-related kidney disease: Kidney injury from paraproteins—What determines the site of injury?.
Pharmacokinetics and pharmacodynamics of extended infusion versus short infusion piperacillin-tazobactam in critically Ill patients undergoing CRRT.
Preoperative vascular medial fibrosis and arteriovenous fistula development.
A patient with recurrent arteriovenous graft thrombosis.
Serum uric acid and risk of CKD in type 2 diabetes.
The ethics of chronic dialysis for the older patient: Time to reevaluate the norms.
A prospective international multicenter study of AKI in the intensive care unit.
Identification of strategies to facilitate organ donation among african americans using the nominal group technique.
Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.
The effects of cinacalcet in older and younger patients on hemodialysis: The evaluation of cinacalcet HCL therapy to lower cardiovascular events (EVOLVE) trial.
Renal relevant radiology: Use of ultrasonography in patients with AKI.
Change in albuminuria and eGFR following insulin sensitization therapy versus insulin provision therapy in the BARI 2D study.
A patient with AKI after cardiac surgery.
Nondisease-specific problems and all-cause mortality among older adults with CKD: The REGARDS study.
The demented patient who declines to be dialyzed and the unhappy armed police officer son: What should be done?.
Metabolic subtypes and risk of mortality in normal weight, overweight, and obese individuals with CKD.
Novel paradigms for dialysis vascular access: Downstream vascular biology-is there a final common pathway?.
Novel paradigms for dialysis vascular access: Introduction.
Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes.
Prevalence of apparent treatment-resistant hypertension among individuals with CKD.
Future of medicare immunosuppressive drug coverage for kidney transplant recipients in the United States.
Segmentation of individual renal cysts from mr images in patients with autosomal dominant polycystic kidney disease.
Age at graft loss after pediatric kidney transplantation: Exploring the high-risk age window.
Effects of dietary phosphate restriction and phosphate binders on FGF23 levels in CKD.
Long-term outcomes of arteriovenous thigh grafts in hemodialysis patients: A comparison with tunneled dialysis catheters.
AKI associated with synthetic cannabinoids: A case series.
Parietal epithelial cell activation marker in early recurrence of FSGS in the transplant.
Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney.
Long-Term renal and cardiovascular outcomes in antihypertensive and Lipid-Lowering treatment to prevent heart attack trial (ALLHAT) participants by baseline estimated GFR.
Design of clinical trials in AKI: A report from an NIDDK workshop. Trials of patients with sepsis and in selected hospital settings.
Design of clinical trials in acute kidney injury: A report from an NIDDK workshop-prevention trials.
Design of clinical trials in acute kidney injury: Report from an NIDDK workshop on trial methodology.
Use of secondary prevention medications among adults with reduced kidney function.
Academic interventional nephrology: A model for training, research, and patient care.
Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.
Pharmacokinetics and Pharmacodynamics of Piperacillin-Tazobactam in 42 patients treated with Concomitant CRRT.
(1-34) parathyroid hormone infusion acutely lowers fibroblast growth factor 23 concentrations in adult volunteers.
Racial differences in the incidence of chronic kidney disease.
Age-specific associations of reduced estimated glomerular filtration rate with concurrent chronic kidney disease complications.
Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study.
Late graft loss among pediatric recipients of DCD kidneys.
Age-specific association of reduced estimated glomerular filtration rate and albuminuria with all-cause mortality.
The spectrum of infections in catheter-dependent hemodialysis patients.
Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy.
Arteriovenous graft infection: A comparison of thigh and upper extremity grafts.
Barriers to evaluation and wait listing for kidney transplantation.
Introduction to the well-transplant visit-more than vital signs and a creatinine check.
Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation.
Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.
Dialysis fistula or graft: The role for randomized clinical trials.
Prognostic indicators of renal disease progression in adults with fabry disease: Natural history data from the Fabry Registry.
Galactose-deficient IgA1 in African Americans with IgA nephropathy: Serum levels and heritability.
Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: Updating the "trade-off" hypothesis.
Introduction to the Third Annual Rostand Vitamin D Symposium.
Vitamin D, blood pressure, and African Americans: Toward a unifying hypothesis.
Does the heparin lock concentration affect hemodialysis catheter patency?.
Statin therapy is not associated with improved vascular access outcomes.
Optimizing medication adherence: An ongoing opportunity to improve outcomes after kidney transplantation.
Development, implementation, and results of the ASN in-training examination for fellows.
Enzyme replacement therapy and fabry nephropathy.
Introduction to focus on Fabry nephropathy: Biomarkers, progression, and disease severity.
Chronic calcineurin inhibitor nephrotoxicity: Reflections on an evolving paradigm.
Clinical outcomes of dialysis catheter-related candidemia in hemodialysis patients.
Does heparin coating improve patency or reduce infection of tunneled dialysis catheters?.
Mineralocorticoid receptor blockers and chronic kidney disease.
Quality of life in autosomal dominant polycystic kidney disease patients not yet on dialysis.
A Festschrift honoring Dr. John J. Curtis..
Must health literacy be a prerequisite for kidney transplantation?.
Outcomes of brachiocephalic fistulas, transposed brachiobasilic fistulas, and upper arm grafts.
Introduction to vitamin D symposium, March 14, 2008.
Evaluation and initial management of acute kidney injury.
Delivery of renal replacement therapy in acute kidney injury: What are the key issues?.
Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified delphi process.
Disparities in fistula maturation persist despite preoperative vascular mapping.
Kidney transplantation as primary therapy for end-stage renal disease: A National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQI™) conference.
Association between serum β2-microglobulin level and infectious mortality in hemodialysis patients.
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: The Treating to New Targets (TNT) study.
Reliability of urinary albumin, total protein, and creatinine assays after prolonged storage: The family investigation of nephropathy and diabetes.
Role of β3 integrin in acute renal allograft rejection in humans.
Current management of vascular access.
Septic acute kidney injury in critically ill patients: Clinical characteristics and outcomes.
A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance..
Clinical trial to evaluate omega-3 fatty acids and alternate day prednisone in patients with IgA nephropathy: report from the Southwest Pediatric Nephrology Study Group..
Survival advantage of black patients with kidney disease after acute myocardial infarction..